Health Care/Hospital News & Press Release Distribution

HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director and CEO

SYDNEY, Nov. 13, 2023 /PRNewswire/ -- HaemaLogiX Ltd, a clinical stage Australian biotech, is pleased to announce the appointment ofDamian Clarke-Bruce as Managing Director and CEO, effective13 November 2023. Outgoing CEO Bryce Carmine will remain active in the company, retaining his role as Cha...

2023-11-14 08:27 1046

Brii Bio Presents New Data Highlighting Progress Towards Achieving HBV Functional Cure at AASLD's The Liver Meeting® 2023

Direct evidence that BRII-179-induced functional antibody responses can contribute to increased and sustained HBsAg loss rate New insight in utilizing BRII-179 to enriching patients with intrinsic humoral immune responses for higher HBsAg loss or HBV functional cure rates New data support ...

2023-11-14 06:40 1230

Brii Bio Presents New Data Highlighting Progress Towards Achieving HBV Functional Cure at AASLD's The Liver Meeting® 2023

Direct evidence that BRII-179-induced functional antibody responses can contribute to increased and sustained HBsAg loss rate New insight in utilizing BRII-179 to enriching patients with intrinsic humoral immune responses for higher HBsAg loss or HBV functional cure rates New data support ...

2023-11-14 06:40 1397

Telix Announces Proposed Acquisition of QSAM Biosciences and Its Lead Therapy Candidate, CycloSam®

MELBOURNE, Australia, Nov. 14, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed a conditional Term Sheet to acquire QSAM Biosciences, Inc. (QSAM) and its lead asset, CycloSam® (Samarium-153-DOTMP). QSAM is a United States (U.S.) based...

2023-11-14 06:33 1222

Rx-360 Releases Two New Publications in Support of the Pharmaceutical Industry and Patient Safety

PHILADELPHIA, Nov. 14, 2023 /PRNewswire/ -- Rx-360 is pleased to announce that the consortium membership led by key members of the Supplier Quality Working Group have released two new papers this week to help drive best practices in pharmaceutical supply chain integrity and patient safety. The t...

2023-11-14 03:00 1352

SCG Cell Therapy Announces Late-Breaking Clinical Data at AASLD Showing SCG101 Improved Tumor Reponses and Achieved Sustained Antiviral Activates in Patients with Advanced HBV-related Hepatocellular Carcinoma

SINGAPORE, Nov. 14, 2023 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today announced late-breaking clinical data from its first-in-class autologous hepatitis B virus ...

2023-11-14 02:00 2323

More than two in three people with diabetes already have complications at diagnosis, International Diabetes Federation study finds

Global research from the International Diabetes Federation reveals that 72% of people living with diabetes only received their diagnosis because they had at least one of the related complications – such as loss of vision, nerve damage or heart disease. BRUSSELS, Nov. 14, 2023 /PRNewswire/ -- Sev...

2023-11-14 00:36 1444

Illumina launches Global Health Access Initiative to support acceleration of pathogen sequencing in low- and middle-income countries

Program aims to address key barriers to genomic sequencing in-country SAN DIEGO, Nov. 13, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the launch of the Global Health Access Initiative to support access to p...

2023-11-13 22:15 1458

Agora Announces RTE Telehealth, A Webinar Exploring the Impact of AI and AR/VR in Virtual Healthcare

The dual session will explore how emerging technologies can improve patient interaction and healthcare delivery in telehealth SANTA CLARA, Calif., Nov. 13, 2023 /PRNewswire/ -- Agora, Inc. (NASDAQ: API), a pioneer and leading platform for real-time engagement APIs, has announced its RTE Teleheal...

2023-11-13 22:00 1286

OliPass Discloses Painful but Hilarious Clinical Findings from a Phase 2a Trial in OA Patients with Nav1.7 Selective Inhibitor OLP-1002

SEOUL, South Korea, Nov. 13, 2023 /PRNewswire/ -- OliPass Corporation, an RNA therapeutics platform company, disclosed uncanny clinical findings from a multi-center Phase 2a trial with Nav1.7 selective OLP-1002 in osteoarthritis (OA) patients with moderate to severe pain inAustralia with Novotech...

2023-11-13 22:00 1126

Lunit, a Founding Member of CancerX, Showcased in the Inaugural Project to Improve Equity and Reduce Financial Toxicity in Cancer Care

- Lunit INSIGHT suite, Lunit's AI-driven solutions for early detection of cancer, featured in CancerX's first official project: enhancing equity and reducing financial burden in cancer care SEOUL, South Korea, Nov. 13, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered ...

2023-11-13 22:00 1144

Lunit, a Founding Member of CancerX, Showcased in the Inaugural Project to Improve Equity and Reduce Financial Toxicity in Cancer Care

LIFE FITNESS ANNOUNCES SYMBIO, A FIRST-OF-ITS-KIND PREMIUM CARDIO LINE, REIMAGINING THE FITNESS EXPERIENCE

ROSEMONT, Ill., Nov. 13, 2023 /PRNewswire/ -- Life Fitness, the global leader in commercial fitness equipment, today announced the launch of its cardio line, Symbio™, an immersive, four-machine collection. Life Fitnes...

2023-11-13 22:00 1910

Datasea Reports First Quarter Fiscal Year 2024 Financial Results and Operations Update

BEIJING, Nov. 13, 2023 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a global technology company that develops and provides products utilizing intelligent acoustics including ultrasound, infrasound and directional sound, and provides 5G messaging, today announced its f...

2023-11-13 21:30 1927

DFS GROUP Collaborates with Galaxy Macau to Spread Positive Energy with Wellness

Discover " The Best Of You, Now "Hong Kong HONG KONG, Nov. 13, 2023 /PRNewswire/ -- This autumn and winter, DFS Group, the world's leading luxury travel retail company, is partnering with Galaxy Macau™ Integrated Resort to launch a wellness-themed event at DFS's first "green" store in their net...

2023-11-13 21:15 1533

DFS GROUP Collaborates with Galaxy Macau to Spread Positive Energy with Wellness

AnchorDx, DiaCarta Partner Developing Novel Cancer Screening Tests

GUANGZHOU, China, Nov. 13, 2023 /PRNewswire/ -- AnchorDx, a leading diagnostics company developing cancer early detection tests, announced today that it has entered into a long-term collaboration with DiaCarta, a precision molecular diagnostics company and developer of novel oncology and infectio...

2023-11-13 21:00 1034

AnchorDx, DiaCarta Partner Developing Novel Cancer Screening Tests

GUANGZHOU, China, Nov. 13, 2023 /PRNewswire/ -- AnchorDx, a leading diagnostics company developing cancer early detection tests, announced today that it has entered into a long-term collaboration with DiaCarta, a precision molecular diagnostics company and developer of novel oncology and infectio...

2023-11-13 21:00 1274

PYC'S FOURTH DRUG CANDIDATE HAS DISEASE-MODIFYING POTENTIAL IN POLYCYSTIC KIDNEY DISEASE

* PYC has developed a new drug candidate for the >5 million people worldwide [1] with Polycystic Kidney Disease (PKD) * This drug candidate has demonstrated efficacy in human models derived from the kidneys of patients with end-stage renal failure due to PKD[2] * PKD is a life-changing diseas...

2023-11-13 21:00 1162

PYC'S FOURTH DRUG CANDIDATE HAS DISEASE-MODIFYING POTENTIAL IN POLYCYSTIC KIDNEY DISEASE

Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

Bylvay (odevixibat) is the first and only oral treatment available in Canada for the treatment of pruritus due to this rare genetic condition ZUG, Switzerland and PARIS, Nov. 13, 2023 /PRNewswire/ -- Today, Ipsen (Euronext: IPN) (ADR: IPSEY), a global biopharmaceutical c...

2023-11-13 20:20 1113

So-Young's Subsidiary Wuhan Miracle Submits Application Documents for Initial Public Offering on China's Beijing Stock Exchange

BEIJING, Nov. 13, 2023 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that its subsidiary Miracle L...

2023-11-13 19:30 1817

TB Alliance Applauds Macleods' Launch of a Key Component of WHO-Recommended Drug-Resistant TB Treatment Regimen

Macleods becomes second pharmaceutical manufacturer to bring pretomanid supply to market and first since the World Health Organization issued updated DR-TB treatment guidelines NEW YORK, Nov. 13, 2023 /PRNewswire/ -- Indian pharmaceutical company Macleods has become the second manufacturer to la...

2023-11-13 18:31 1124